Clinical chemistry cost per reportable result
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- W9114F26DA005
- Awardee
-
Roche Diagnostics S.P.A. UEI CRBLKCZC9XC6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Task orders
- 2 $45,817 obligated
Award facts
- Opportunity
-
- Blood Chemistry Testing - Cost Per Reportable Result Pre-Solicitation · W9114F26QA010 · Posted Oct 31, 2025
- Combined order value
- $45,817 Current and potential, with all options
- Last date to order 16% complete
- IDV ceiling 6% used
- $830,000.00
- Maximum order
- $100,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 14 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Health Agency awarded an indefinite-delivery contract to Roche Diagnostics S.P.A. on January 1, 2026, for clinical chemistry cost per reportable result services, with a ceiling value of $830,000.00 and ultimate completion date of December 31, 2030. This is a single-award IDIQ with no set-aside designation.
Work is performed in Italy. The contract supports procurement of an automated clinical chemistry analyzer with associated consumables, reagents, controls, and maintenance services for the U.S. Army Health Clinic in Vicenza, Italy. The analyzer performs 27 different blood chemistry tests with random access capabilities, STAT interrupt functionality, and primary tube sampling for multiple tube types, all meeting FDA approval standards. The contractor is fully responsible for equipment delivery, all supplies, equipment maintenance, emergency replacement within 7 business days upon equipment failure, operating manuals, and operator training.
The contract structure employs a Cost Per Reportable Result (CPRR) pricing model with estimated annual clinical chemistry workload of 42,595 tests across the 27 specified test types. Period of performance includes a two-month phase-in from January 2 through February 28, 2026, followed by one ordering period from March 1, 2026 through December 31, 2030. NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) applies.
Two delivery orders have been issued under this IDIQ as of March 1, 2026: a $3,439.76 firm fixed-price order issued January 2, 2026, with completion date February 28, 2026, and a $42,377.73 firm fixed-price order issued March 1, 2026, with completion date September 30, 2026, both for clinical chemistry cost per reportable result services performed in Italy.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Clinical chemistry cost per reportable result | Defense Health Agency | $42,378 | |
| Clinical chemistry cost per reportable result | Defense Health Agency | $3,440 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract W9114F26DA005?
W9114F26DA005 was awarded to Roche Diagnostics S.P.A. by Defense Health Agency (Department of Defense) on January 1, 2026.
How much is contract W9114F26DA005 worth?
Orders under W9114F26DA005 have obligated $45,817. W9114F26DA005's own ceiling is $830,000. A single order can be worth up to $100,000.
How many orders have been placed under contract W9114F26DA005?
2 orders have been placed under W9114F26DA005, the latest on March 1, 2026.
Who can order from contract W9114F26DA005?
W9114F26DA005 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract W9114F26DA005 competed?
The extent of competition for W9114F26DA005 was competed under sap. The government received 14 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV